Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinoma.

K Nadarasa, A Theodoraki, T R Kurzawinski, R Carpenter, J Bull, T T Chung and W M Drake Department of Endocrinology, St Bartholomew’s Hospital, London, UK, Department of Diabetes and Endocrinology, UCLH NHS Foundation Trust, London, UK, Department of Endocrine Surgery, UCLH NHS Foundation Trust, London, UK and Department of Neurosurgery, The Royal London Hospital, London, UK (K Nadarasa and A Theodoraki contributed equally to this work)